2Faller G,Borchard F,Ell C,et al.Histopathological diagnosis of Barrett's mucosa and associated neoplasias:results of a consensus conference of the Working Group for Gastroenterological Pathology of the German Society for Pathology on 22 September 2001 in Erlangen.Virchows Arch,2003,443:597-601.
3Sampliner RE.Practice guidelines on the diagnosis,surveillance,and therapy of Barrett's esophagus.Am J Gastroenterol,1998,93:1028-1032.
4Levine DS.Management of dysplasia in the columnar-lined esophagus.Gastroenterol Clin North Am,1997,26:613-634.
5Douglas S,Levine MD,Patricia L,et al.Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus.Am J Gastroenterol,2000,95:1152-1157.
6Egger K,Werner M,Meining A,et al.Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques.Gut,2003,52:18 -23.
7Spechler SJ.Dysplasia in Barrett's esophagus:Limitations of current management stragies.Am J Gastroenterol,2005,100:927-935.
8Morgan C,Alazawi W,Sirieix P,et al.In vitro acid exposure has a differential effect on apoptotic and proliferative pathways in a Barretfs adenocarcinoma cell line.Am J Gastroenterol,2004,99:218-224.
